The NordICC-study group is nominated for the category Best Scientific Work by the Felix Burda Award 2017

Centre PI Michael Bretthauer and the NordICC-study group is nominated for the prestigious German research prize The Felix Burda Award 2017 for Best Scientific Work. The prize is awarded in Berlin on the 14 of May at a gala venue broadcasted on German television.

Principal investigator Michael Bretthauer

Link to news article in Norwegian from the The Clinical Effectiveness Research Group homepage: Norske leger nominert til prestisjetung tysk forskningspris

Latest publications

Smeby et al. 2019. Transcriptional and functional consequences of TP53 splice mutations in colorectal cancer. Oncogenesis 8(6): 35 Kryeziu et al., 2019. Combination therapies with HSP90 inhibitors against colorectal cancer. BBA Reviews on Cancer, 1871(2): 240-247 Eilertsen IA et al., 2019. Alternative splicing expands the prognostic impact of KRAS in microsatellite stable primary colorectal cancer. Int J Cancer, 144(4): 841-847 Røsok et al., 2019. Characterization of early recurrences following liver resection by ALPPS and two stage hepatectomy in patients with colorectal liver-metastases and small future liver remnants; a translational substudy of the LIGRO-RCT. HPB (Oxford), [Epub ahead of print] Röhrl et al., 2019. Symptoms during chemotherapy in colorectal cancer patients. Support Care Cancer, [Epub ahead of print] All publications